Provencio, M., de Lope, L., Serna-Blasco, R., Nadal, E., Tain, P., Massuti, B., . . . Romero, A. (2024). BRAF mutational status is associated with survival outcomes in locally advanced resectable and metastatic NSCLC.
Citación estilo ChicagoProvencio, M., et al. BRAF Mutational Status Is Associated With Survival Outcomes in Locally Advanced Resectable and Metastatic NSCLC. 2024.
Cita MLAProvencio, M., et al. BRAF Mutational Status Is Associated With Survival Outcomes in Locally Advanced Resectable and Metastatic NSCLC. 2024.
Precaución: Estas citas no son 100% exactas.